Skip to content

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

Poison pill unlikely to end the battle for Twitter shares

The Twitter board has rejected Elon Musk’s offer to take the social media company private, and instead implemented the highly successful poison pill defence.

twitter Source: Bloomberg

Elon Musk has plenty of reasons to gain control of Twitter (NYSE: TWTR). And after spending $2.9 billion acquiring 9.3% of the social media company’s shares, it appeared as though he would take a board seat to influence its strategy.

However, the eccentric billionaire has declined the seat and is now after complete ownership of Twitter as a private company.

Twitter share price: poison pill

After turning down the seat, Musk notified the social media company he intended to purchase ‘100% of Twitter for $54.20 per share in cash, a 54% premium over the day before I began investing in Twitter and a 38% premium over the day before my investment was publicly announced.’

The Tesla founder argued that Twitter had the ‘potential to be the platform for free speech around the globe’ but that ‘the company will neither thrive nor serve this societal imperative in its current form. Twitter needs to be transformed as a private company.’

The billionaire further clarified that it was his best and final offer, emphasising he would not be ‘playing the back-and-forth game,’ and that the offer was ‘high price and your shareholders will love it.’

In response, Twitter’s board blocked the takeover offer and unanimously declared a limited-duration shareholder rights plan, aptly dubbed the poison pill strategy. This defence allows existing shareholders to buy new Twitter shares at half the market price if any shareholder were to acquire more than 15% of the company without board approval.

The strategy has been highly successful in the past and provides a strong disincentive for Musk to pursue a hostile takeover. The poison pill expires on 14 April 2023.

Musk had warned that if the board rejected his offer, he ‘would need to reconsider my position as a shareholder,’ claiming ‘this is not a threat, it’s simply not a good investment without the changes that need to be made.’

elon musk Source: Bloomberg

Where next for Twitter shares?

The trajectory of Twitter’s share price is now unclear. In the worst-case scenario, Musk could dump his entire shareholding onto the market. Of course, despite his declaration, he could also issue an improved offer.

But CEO Parag Agrawal believes the company is not being ‘held hostage’ by Musk’s offer, and that ‘we as employees control what happens.’

And Twitter has emphasised that its poison pill ‘does not prevent the Board from engaging with parties or accepting an acquisition proposal if the Board believes that it is in the best interests of Twitter and its shareholders.’

A bidding war could erupt. Thoma Bravo LP has contacted Twitter to express interest in a competing offer, while Vanguard has increased its shareholding to 10.3%, surpassing Musk’s 9.3%.

And Musk is now talking to potential takeover partners, including private equity firm Silver Lake. Silver Lake co-CEO Egon Durban is a Twitter board member and reportedly led Musk’s failed attempt to take Tesla private in 2018.

And Twitter’s board collectively only owns 0.12% of Twitter shares. This led Musk to declare, not unreasonably, that ‘objectively, their economic interests are simply not aligned with shareholders.’ CEO Agrawal only owns 0.063%.

Musk believes that refusing the deal is tantamount to ‘breaching their fiduciary duty,’ and moreover that the board would assume liability ‘titanic in scale.’ And by rejecting such a high premium, Twitter’s board is now at risk of lawsuits from shareholders. Some may even argue they prioritised their own roles with Musk declaring ‘I don’t have confidence in management.’

However, Twitter’s share price was $77.06 in February 2021, and the board could well argue the offer does not reflect Twitter’s growth prospects. Of course, Musk could also make a direct tender offer to shareholders, eliminating the need for board approval.

But another possibility comes from Twitter co-founder and former CEO Jack Dorsey. Quitting the board next month, he’s argued it’s ‘consistently the dysfunction of the company.’

Dorsey is now better known as the founder and CEO of Block. The payments company incorporates Square as well as Bitcoin-focussed Spiral and decentralised finance project TBD.

Intriguingly, he joined the board of Twitter-funded social media project Bluesky in February, three months after stepping down as Twitter’s CEO. The decentralised nature of the project chimes with Musk’s championing of free speech.

With so many variables, Twitter shares will remain all aflutter.

Trade over 16,000 international shares from zero commission with us, the UK’s No.1 trading provider.* Learn more about trading shares with us, or open an account to get started today.

*Based on revenue (published financial statements, 2022).

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

Act on share opportunities today

Go long or short on thousands of international stocks with spread bets and CFDs.

  • Get full exposure for a comparatively small deposit
  • Trade on spreads from just 0.1%
  • Get greater order book visibility with direct market access

See opportunity on a stock?

Try a risk-free trade in your demo account, and see whether you’re on to something.

  • Log in to your demo
  • Take your position
  • See whether your hunch pays off

See opportunity on a stock?

Don’t miss your chance – upgrade to a live account to take advantage.

  • Trade a huge range of popular stocks
  • Analyse and deal seamlessly on fast, intuitive charts
  • See and react to breaking news in-platform

See opportunity on a stock?

Don’t miss your chance. Log in to take advantage while conditions prevail.

Live prices on most popular markets

  • Equities
  • Indices
  • Forex
  • Commodities
website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

" >


Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Sunday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.


For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.